Treatment of hepatotoxicity with IL-11 antibody
US11319368B2 · kind B2 · utility
0Cited by
17References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 21, 2020 |
| Grant date | May 3, 2022 |
| Priority date | — |
| Expiry date | Jan 21, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating and preventing hepatotoxicity through inhibiting interleukin 11 (IL-11)-mediated signalling are disclosed, as well as agents for use in such methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.